Cargando…

Decreased level of soluble receptor activator of nuclear factor-κβ ligand (sRANKL) in overweight and obese children

INTRODUCTION: Childhood obesity contributes to the development of cardiovascular diseases. The molecular pathway – receptor activator of nuclear factor-κβ ligand (RANKL), its receptor RANK and osteoprotegerin (OPG) - takes part not only in bone metabolism but is also involved in the atherosclerosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Erazmus, Michał, Rumińska, Małgorzata, Witkowska-Sędek, Ewelina, Kucharska, Anna M., Stelmaszczyk-Emmel, Anna, Majcher, Anna, Pyrżak, Beata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437335/
https://www.ncbi.nlm.nih.gov/pubmed/36060948
http://dx.doi.org/10.3389/fendo.2022.963467
_version_ 1784781583552610304
author Erazmus, Michał
Rumińska, Małgorzata
Witkowska-Sędek, Ewelina
Kucharska, Anna M.
Stelmaszczyk-Emmel, Anna
Majcher, Anna
Pyrżak, Beata
author_facet Erazmus, Michał
Rumińska, Małgorzata
Witkowska-Sędek, Ewelina
Kucharska, Anna M.
Stelmaszczyk-Emmel, Anna
Majcher, Anna
Pyrżak, Beata
author_sort Erazmus, Michał
collection PubMed
description INTRODUCTION: Childhood obesity contributes to the development of cardiovascular diseases. The molecular pathway – receptor activator of nuclear factor-κβ ligand (RANKL), its receptor RANK and osteoprotegerin (OPG) - takes part not only in bone metabolism but is also involved in the atherosclerosis process. RANKL stimulates osteogenic differentiation and calcification of vascular smooth cells. The associations between the OPG-sRANKL system and various cardiovascular risk factors were displayed. We aimed to evaluate the relationships between serum sRANKL (soluble RANKL) levels and the OPG/sRANKL ratio with cardiometabolic risk factors in overweight and obese children. MATERIAL AND METHODS: The study included 70 children with overweight and obesity (mean age 13.0 ± 2.8) and 35 age-matched normal weight, healthy peers as a control group. In all patients, anthropometric measurements and laboratory tests were performed. Additionally, an oral glucose tolerance test (OGTT) was made only in overweight and obese children. Atherogenic and insulin resistance indices were calculated. RESULTS: Overweight and obese children had lower sRANKL levels compared to the control group (median 276.95 vs 325.90, p=0.011), and consequently a higher OPG/sRANKL ratio (0.02 vs 0.01, p = 0.013). The studied children in the lowest quartile of sRANKL levels had higher body weight, Body Mass Index, waist circumference and increased glucose and insulin levels 60 minutes after OGTT and higher uric acid values compared to children in the highest quartile. In multivariable linear regression analysis sRANKL negatively correlated only with uric acid (β = - 0.508, p = 0.041). No association was found for the OPG/sRANKL ratio. CONCLUSION: Excess fat mass seems to alter the OPG/RANKL ratio mainly by reducing serum sRANKL levels. The correlation between sRANKL and uric acid may suggest a contribution of the OPG-sRANKL system in the cardiometabolic process, but that observation should be confirmed in future studies.
format Online
Article
Text
id pubmed-9437335
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-94373352022-09-03 Decreased level of soluble receptor activator of nuclear factor-κβ ligand (sRANKL) in overweight and obese children Erazmus, Michał Rumińska, Małgorzata Witkowska-Sędek, Ewelina Kucharska, Anna M. Stelmaszczyk-Emmel, Anna Majcher, Anna Pyrżak, Beata Front Endocrinol (Lausanne) Endocrinology INTRODUCTION: Childhood obesity contributes to the development of cardiovascular diseases. The molecular pathway – receptor activator of nuclear factor-κβ ligand (RANKL), its receptor RANK and osteoprotegerin (OPG) - takes part not only in bone metabolism but is also involved in the atherosclerosis process. RANKL stimulates osteogenic differentiation and calcification of vascular smooth cells. The associations between the OPG-sRANKL system and various cardiovascular risk factors were displayed. We aimed to evaluate the relationships between serum sRANKL (soluble RANKL) levels and the OPG/sRANKL ratio with cardiometabolic risk factors in overweight and obese children. MATERIAL AND METHODS: The study included 70 children with overweight and obesity (mean age 13.0 ± 2.8) and 35 age-matched normal weight, healthy peers as a control group. In all patients, anthropometric measurements and laboratory tests were performed. Additionally, an oral glucose tolerance test (OGTT) was made only in overweight and obese children. Atherogenic and insulin resistance indices were calculated. RESULTS: Overweight and obese children had lower sRANKL levels compared to the control group (median 276.95 vs 325.90, p=0.011), and consequently a higher OPG/sRANKL ratio (0.02 vs 0.01, p = 0.013). The studied children in the lowest quartile of sRANKL levels had higher body weight, Body Mass Index, waist circumference and increased glucose and insulin levels 60 minutes after OGTT and higher uric acid values compared to children in the highest quartile. In multivariable linear regression analysis sRANKL negatively correlated only with uric acid (β = - 0.508, p = 0.041). No association was found for the OPG/sRANKL ratio. CONCLUSION: Excess fat mass seems to alter the OPG/RANKL ratio mainly by reducing serum sRANKL levels. The correlation between sRANKL and uric acid may suggest a contribution of the OPG-sRANKL system in the cardiometabolic process, but that observation should be confirmed in future studies. Frontiers Media S.A. 2022-08-19 /pmc/articles/PMC9437335/ /pubmed/36060948 http://dx.doi.org/10.3389/fendo.2022.963467 Text en Copyright © 2022 Erazmus, Rumińska, Witkowska-Sędek, Kucharska, Stelmaszczyk-Emmel, Majcher and Pyrżak https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Erazmus, Michał
Rumińska, Małgorzata
Witkowska-Sędek, Ewelina
Kucharska, Anna M.
Stelmaszczyk-Emmel, Anna
Majcher, Anna
Pyrżak, Beata
Decreased level of soluble receptor activator of nuclear factor-κβ ligand (sRANKL) in overweight and obese children
title Decreased level of soluble receptor activator of nuclear factor-κβ ligand (sRANKL) in overweight and obese children
title_full Decreased level of soluble receptor activator of nuclear factor-κβ ligand (sRANKL) in overweight and obese children
title_fullStr Decreased level of soluble receptor activator of nuclear factor-κβ ligand (sRANKL) in overweight and obese children
title_full_unstemmed Decreased level of soluble receptor activator of nuclear factor-κβ ligand (sRANKL) in overweight and obese children
title_short Decreased level of soluble receptor activator of nuclear factor-κβ ligand (sRANKL) in overweight and obese children
title_sort decreased level of soluble receptor activator of nuclear factor-κβ ligand (srankl) in overweight and obese children
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437335/
https://www.ncbi.nlm.nih.gov/pubmed/36060948
http://dx.doi.org/10.3389/fendo.2022.963467
work_keys_str_mv AT erazmusmichał decreasedlevelofsolublereceptoractivatorofnuclearfactorkbligandsranklinoverweightandobesechildren
AT ruminskamałgorzata decreasedlevelofsolublereceptoractivatorofnuclearfactorkbligandsranklinoverweightandobesechildren
AT witkowskasedekewelina decreasedlevelofsolublereceptoractivatorofnuclearfactorkbligandsranklinoverweightandobesechildren
AT kucharskaannam decreasedlevelofsolublereceptoractivatorofnuclearfactorkbligandsranklinoverweightandobesechildren
AT stelmaszczykemmelanna decreasedlevelofsolublereceptoractivatorofnuclearfactorkbligandsranklinoverweightandobesechildren
AT majcheranna decreasedlevelofsolublereceptoractivatorofnuclearfactorkbligandsranklinoverweightandobesechildren
AT pyrzakbeata decreasedlevelofsolublereceptoractivatorofnuclearfactorkbligandsranklinoverweightandobesechildren